Related Experiment Video
Updated: Feb 8, 2026

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
Establishment of COS-JC cells persistently producing archetype JC polyomavirus
Souichi Nukuzuma1, Chiyoko Nukuzuma2, Masanori Kameoka3
1Department of Infectious Diseases, Kobe Institute of Health, 4-6-5, Minatojima, -Nakamachi, Chuo-ku, Kobe 650-0046, Japan.
Abstract:
JC polyomavirus (JCPyV) is the causative agent of progressive multifocal leukoencephalopathy (PML), a demyelinating disease of the central nervous system in immunocompromised patients. Archetype JCPyV circulates in the human population. There have been several reports of archetype JCPyV replication in cultured cells, in which propagation was not enough to produce high titers of archetype JCPyV. In this study, we carried out cultivation of the transfected cells with archetype JCPyV DNA MY for more than 2 months to establish COS-7 cells (designated COS-JC cells) persistently producing archetype JCPyV. Moreover, JCPyV derived from COS-JC cells was characterized by analyzing the viral propagation, size of the viral genome, amount of viral DNA, production of viral protein, and structure of the non-coding control region (NCCR). Southern blotting using a digoxigenin-labeled JCPyV probe showed two different sizes of the JCPyV genome in COS-JC cells. For molecular cloning, four of five clones showed a decrease in the size of complete JCPyV genome. Especially, clone No. 10 was generated the large deletion within the Large T antigen. On the other hand, the archetype structure of the NCCR was maintained in COS-JC cells, although a few point mutations occurred. Quantitative PCR analysis of viral DNA in COS-JC cells indicated that a high copy number of archetype JCPyV DNA was replicated in COS-JC cells. These findings suggest that COS-JC cells could efficiently propagate archetype JCPyV MY and offer a useful tool to study persistent infection of archetype JCPyV in a kidney-derived system.
Insights
This study establishes COS-JC cells that persistently produce archetype JC polyomavirus (JCPyV), enabling efficient propagation for research into progressive multifocal leukoencephalopathy (PML) and persistent JCPyV infections.
Area of Science:
- Virology
- Molecular Biology
- Infectious Diseases
Background:
- JC polyomavirus (JCPyV) causes progressive multifocal leukoencephalopathy (PML), a serious CNS disease in immunocompromised individuals.
- Archetype JCPyV is common in humans, but efficient cell culture propagation for high-titer production has been challenging.
Purpose of the Study:
- To establish a cell line for persistent, high-titer production of archetype JCPyV.
- To characterize the viral properties and genome of JCPyV produced in the established cell line.
Main Methods:
- Cultivation of archetype JCPyV DNA-transfected COS-7 cells for over 2 months to create persistently producing COS-JC cells.
- Analysis of viral propagation, genome size, DNA amount, protein production, and NCCR structure using Southern blotting and quantitative PCR.
Main Results:
- COS-JC cells persistently produced archetype JCPyV at high copy numbers.
- Southern blotting revealed two JCPyV genome sizes; molecular cloning showed genome size reduction in some clones, with one exhibiting a large deletion in the Large T antigen.
- The archetype non-coding control region (NCCR) structure was largely maintained with minor point mutations.
Conclusions:
- The established COS-JC cell line efficiently propagates archetype JCPyV MY.
- COS-JC cells provide a valuable tool for studying persistent JCPyV infections, particularly in a kidney-derived system.
Related Concept Videos
Clinically Relevant Drug Product Specifications: Methods of Establishment
Cell Size
Surface Area
Cells can take in nutrients and water via diffusion through the plasma membrane itself or through specific channels in the membrane. The area of the membrane surrounding...
Adult Stem Cells
Embryonic Stem Cells
Cell Specific Gene Expression
Induced Pluripotent Stem Cells

